Annotation de séquence moléculaire : Questions médicales fréquentes
Nom anglais: Molecular Sequence Annotation
Descriptor UI:D058977
Tree Number:L01.462.750.245.667.580
Termes MeSH sélectionnés :
Research Design
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Annotation de séquence moléculaire : Questions médicales les plus fréquentes",
"headline": "Annotation de séquence moléculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Annotation de séquence moléculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-02-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Annotation de séquence moléculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Données de séquences moléculaires",
"url": "https://questionsmedicales.fr/mesh/D008969",
"about": {
"@type": "MedicalCondition",
"name": "Données de séquences moléculaires",
"code": {
"@type": "MedicalCode",
"code": "D008969",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.462.750.245.667"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Annotation de séquence moléculaire",
"alternateName": "Molecular Sequence Annotation",
"code": {
"@type": "MedicalCode",
"code": "D058977",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Eneida L Hatcher",
"url": "https://questionsmedicales.fr/author/Eneida%20L%20Hatcher",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Linda Yankie",
"url": "https://questionsmedicales.fr/author/Linda%20Yankie",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Eric P Nawrocki",
"url": "https://questionsmedicales.fr/author/Eric%20P%20Nawrocki",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Jack W Roddy",
"url": "https://questionsmedicales.fr/author/Jack%20W%20Roddy",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Science, University of Montana, Missoula, MT 59812, USA."
}
},
{
"@type": "Person",
"name": "Travis J Wheeler",
"url": "https://questionsmedicales.fr/author/Travis%20J%20Wheeler",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Science, University of Montana, Missoula, MT 59812, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37434136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-023-01971-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of research co-design in health: a systematic overview of reviews and development of a framework.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39261956",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13012-024-01394-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engaging community members in cancer research: an assessment of an NCI-designated cancer center.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36598655",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10552-022-01666-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Conducting Implementation Research in Stroke Rehabilitation: A Case Example and Considerations for Study Design.",
"datePublished": "2022-11-18",
"url": "https://questionsmedicales.fr/article/36398961",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/15459683221138747"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-case experimental designs for child neurological rehabilitation and developmental disability research.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36721909",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/dmcn.15513"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences de l'information",
"item": "https://questionsmedicales.fr/mesh/D007254"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sources d'information",
"item": "https://questionsmedicales.fr/mesh/D000093983"
},
{
"@type": "ListItem",
"position": 4,
"name": "Services d'information",
"item": "https://questionsmedicales.fr/mesh/D007255"
},
{
"@type": "ListItem",
"position": 5,
"name": "Documentation",
"item": "https://questionsmedicales.fr/mesh/D004282"
},
{
"@type": "ListItem",
"position": 6,
"name": "Données de séquences moléculaires",
"item": "https://questionsmedicales.fr/mesh/D008969"
},
{
"@type": "ListItem",
"position": 7,
"name": "Annotation de séquence moléculaire",
"item": "https://questionsmedicales.fr/mesh/D058977"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Annotation de séquence moléculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Annotation de séquence moléculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Annotation de séquence moléculaire",
"description": "Comment l'annotation aide-t-elle au diagnostic ?\nQuels outils sont utilisés pour l'annotation ?\nL'annotation peut-elle prédire des maladies ?\nQuels types de séquences sont annotés ?\nL'annotation est-elle standardisée ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Annotation de séquence moléculaire",
"description": "Quels symptômes peuvent être liés à des mutations génétiques ?\nComment l'annotation aide-t-elle à comprendre les symptômes ?\nLes symptômes sont-ils toujours présents avec des mutations ?\nPeut-on prédire des symptômes grâce à l'annotation ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Annotation de séquence moléculaire",
"description": "Comment l'annotation aide-t-elle à la prévention ?\nPeut-on prévenir des maladies grâce à l'annotation ?\nQuels tests sont utilisés pour l'annotation préventive ?\nL'éducation génétique est-elle importante pour la prévention ?\nLes programmes de dépistage sont-ils basés sur l'annotation ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Annotation de séquence moléculaire",
"description": "L'annotation influence-t-elle les traitements ?\nQuels traitements sont basés sur l'annotation ?\nComment l'annotation aide-t-elle à choisir un traitement ?\nLes traitements sont-ils standardisés selon l'annotation ?\nL'annotation peut-elle aider à éviter des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Annotation de séquence moléculaire",
"description": "Quelles complications peuvent survenir sans annotation ?\nL'annotation peut-elle réduire les complications ?\nLes complications sont-elles prévisibles grâce à l'annotation ?\nComment l'annotation aide-t-elle à gérer les complications ?\nLes complications varient-elles selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Annotation de séquence moléculaire",
"description": "Quels facteurs de risque sont identifiés par l'annotation ?\nL'annotation peut-elle identifier des facteurs de risque environnementaux ?\nLes facteurs de risque sont-ils modifiables ?\nComment l'annotation aide-t-elle à évaluer les facteurs de risque ?\nLes facteurs de risque sont-ils les mêmes pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D058977?mesh_terms=Research+Design&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier des gènes ou des mutations associés à des maladies."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour l'annotation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des logiciels comme BLAST et GeneMark sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "L'annotation peut-elle prédire des maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à prédire des risques génétiques pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels types de séquences sont annotés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquences d'ADN, d'ARN et de protéines sont couramment annotées."
}
},
{
"@type": "Question",
"name": "L'annotation est-elle standardisée ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe des standards comme GFF et BED pour uniformiser l'annotation."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être liés à des mutations génétiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des malformations, des troubles métaboliques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle à comprendre les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle relie les mutations à des phénotypes spécifiques, facilitant la compréhension."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents avec des mutations ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines mutations peuvent être silencieuses et ne pas provoquer de symptômes."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes grâce à l'annotation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'annotation peut aider à anticiper des symptômes basés sur des mutations connues."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'environnement et de la génétique."
}
},
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle à la prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier les individus à risque et de mettre en place des mesures préventives."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir des maladies grâce à l'annotation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en surveillant les individus porteurs de mutations à risque."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'annotation préventive ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques comme le séquençage de nouvelle génération sont utilisés."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle sensibilise les individus aux risques et aux mesures préventives."
}
},
{
"@type": "Question",
"name": "Les programmes de dépistage sont-ils basés sur l'annotation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent conçus en fonction des données d'annotation disponibles."
}
},
{
"@type": "Question",
"name": "L'annotation influence-t-elle les traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet de personnaliser les traitements en fonction des mutations spécifiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont basés sur l'annotation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les thérapies géniques et les médicaments ciblés en dépendent."
}
},
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle à choisir un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle identifie les cibles moléculaires pour des traitements plus efficaces."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils standardisés selon l'annotation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les traitements peuvent varier selon les spécificités de chaque cas."
}
},
{
"@type": "Question",
"name": "L'annotation peut-elle aider à éviter des effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en choisissant des traitements adaptés aux profils génétiques des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans annotation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements inappropriés et des diagnostics erronés peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'annotation peut-elle réduire les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en permettant des traitements plus ciblés et adaptés aux patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles grâce à l'annotation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées en fonction des mutations identifiées."
}
},
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle à gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle fournit des informations sur les risques et les options de traitement appropriées."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les individus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont identifiés par l'annotation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques, des antécédents familiaux et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'annotation peut-elle identifier des facteurs de risque environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut relier des mutations à des expositions environnementales spécifiques."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils modifiables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains, comme le mode de vie, peuvent être modifiés pour réduire les risques."
}
},
{
"@type": "Question",
"name": "Comment l'annotation aide-t-elle à évaluer les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'analyser les données génétiques et cliniques pour une évaluation précise."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils les mêmes pour tous ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils varient selon les individus et les populations en fonction de la génétique."
}
}
]
}
]
}
Frailty, neurodegeneration and geriatric syndromes cause a significant impact at the clinical, social, and economic level, mainly in the context of the aging world. Recently, Information and Communica...
Following the PRISMA guidelines, records from PubMed, EMBASE, and Web of Science were systematically screened to select original articles in which interventional or observational designs were used to ...
Thirty-four articles met the inclusion criteria. Most of the studies used diagnostic accuracy designs to test assessment procedures or retrospective cohort designs to build predictive models. A minori...
The majority of the reviewed articles use an observational design mainly to study diagnostic procedures and suffer from a high risk of bias. The scarce presence of methodologically robust intervention...
Co-design with consumers and healthcare professionals is widely used in applied health research. While this approach appears to be ethically the right thing to do, a rigorous evaluation of its process...
A multifaceted, iterative approach, including three steps, was undertaken to develop a Co-design Evaluation Framework: 1) A systematic overview of reviews; 2) Stakeholder panel meetings to discuss and...
A total of 51 reviews were included in the systematic overview of reviews. Fifteen evaluation themes were identified and grouped into the following seven clusters: People (within co-design group), gro...
The Co-Design Evaluation Framework has been collaboratively developed with various stakeholders to be used prospectively (planning for evaluation), concurrently (making adjustments during the co-desig...
Despite the importance of engaging community members in research, multiple barriers exist. We conducted a mixed-methods evaluation to understand the opportunities and challenges of engaging community ...
We designed a survey and an interview guide based on the constructs of the Consolidated Framework for Implementation Research. Surveys were distributed electronically to all cancer center investigator...
There was strong agreement among investigators that "Community engagement in research will help the SKCC address cancer disparities in the catchment area" (M 4.2, SD 0.9) and less agreement with items...
Cancer centers should develop and promote training and collaborative opportunities for investigators and community members. Overcoming challenges will lead to more patient- and community-centered canc...
As neurorehabilitation research continues to grow, the field must ensure its scientific discoveries are implemented into routine clinical care. Without targeted efforts to increase the implementation ...
Single-case experimental designs (SCEDs) are a group of methodologies of growing interest, aiming to test the effectiveness of an intervention at the single-participant level, using a rigorous and pro...
The prosthetic socket is a key component that influences prosthesis satisfaction, with a poorly fitting prosthetic socket linked to prosthesis abandonment and reduced community participation. This pap...
Systematic literature and patent searches were conducted across multiple databases to identify articles and patents that discussed adjustable prosthetic sockets. The patents were used to find companie...
50 literature articles and 63 patents were identified for inclusion, representing 35 different designs used in literature and 16 commercially available products. Adjustable sockets are becoming more p...
There are clear differences in the design focus taken by industry and researchers, with justification for choice of design and range of adjustment often being unclear. Whilst comfort is often reported...
The randomized controlled trial (RCT) is the gold standard in evidence-based medicine. However, this design may not be appropriate in every setting, so other methods or designs such as the regression ...
The aim of this article is to introduce the RDD, summarise methodology in the context of health services research and present a worked example using the statistic software SPSS (Examples for R and Sta...
The RDD consists of four essential steps: 1. Determine feasibility; 2. Note possible treatment manipulation, 3. Check for the treatment effect, and 4. Fit the regression models to measure the treatmen...
The RDD comes as an alternative for studies in health service research where an RCT cannot be conducted, but a threshold-based comparison can be made....
Participation of people from culturally and linguistically diverse (CALD) communities in public health research is often limited by challenges with recruitment, retention and second-language data coll...
NHLBI funded seven projects as part of the Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Initiative. They were expected to col...
In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of ...